AMPrEP (Amsterdam PrEP)

To investigate the acceptability, feasibility and usability of an HIV infection prevention program for high-risk MSM through 2 different biomedical intervention strategies at the PHSA: daily Pre-exposure prophylaxis (PrEP) and intermittent Pre-exposure prophylaxis. Focuses on interest in using PrEP, compliance/adherence, risk compensation and cost-benefit analysis. The outcomes of the project will be used to inform the discussion around the inclusion of PrEP as a standard intervention for HIV prevention in the Netherlands.